2 results
Approved WMOCompleted
Main objective:To assess the relapse rate (defined by clinical and biochemical parameters) over 24 months in patients with acute AAV presenting at first diagnosis of relapse, after 12 months of treatment with abatacept in combination with steroids…
Approved WMOCompleted
The primary objective for this study is to demonstrate that SC injections of abatacept are non-inferior to IV infusions of abatacept .